15 October 2020

Roche Will Be `Thoughtful' on Regeneron Pricing, CEO Says

WTF is "thoughtful"?
Oct.15 -- Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19. He speaks from Basel, Switzerland, on "Bloomberg Markets: European Open" after Roche's third-quarter sales fell short of estimates.
606 views
Oct 15, 2020 @ time of upload to this blog

No comments:

A Dimension Called " DEPTH OF COMPETITION" | Phys.org

  NOVEMBER 6, 2024 'Shallow' sports and 'deep' social hierarchies: Not all pecking orders are created equally by  University...